Crossmark

CD71<sup>+</sup> erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2022-006595

Published Online: 2023-05-26

Published Print: 2023-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Bozorgmehr, Najmeh

Okoye, Isobel

Mashhouri, Siavash https://orcid.org/0000-0003-4954-6090
Lu, Julia

Koleva, Petya

Walker, John

Elahi, Shokrollah https://orcid.org/0000-0002-7215-2009
Funding

Funding for this research was provided by:

Alberta Cancer Foundation (N/A)

Canadian Institutes of Health Research (148442)
License Information

License valid from 2023-05-26